Most Recent
A judge has told a unit of US energy giant Chevron Corporation to consider narrowing its trade mark dispute against Australian petrol station operator Ampol, as the parties consider whether to take the matter to an expedited hearing.
The Full Federal Court has upheld an appeal by In-N-Out Burgers against Sydney-based Hashtag Burgers, finding that its two sole directors were also liable for trademark infringement and passing off in owning and operating their 'DOWN-N-OUT' burger restaurants.
Casino and mobile game giant Aristocrat Leisure has reached a settlement in its lawsuit against rival Ainsworth Game Technology that alleged a former employee stole trade secrets related to a lucrative slot machine.
Two Melbourne law firms are locked in a courtroom battle over their 'C' trade marks made up of concentric circles, after IP Australia allowed two of the disputed marks to proceed to registration.
The maker of Mother energy drinks has had its Motherland trade mark removed by IP Australia, with a delegate granting a win to rival caffeinated beverage maker Vittoria Food & Beverage in finding that the mark should be removed for non-use.
The Australian chapter of the Hells Angels bikie gang is once again going after online marketplace Redbubble for alleged intellectual property infringement, this time over a range of new products that include face masks bearing the group's famous insignia.
US cryptocurrency maker Ripple Labs has reached a settlement with the company behind the PayID mobile banking system, ending months of litigation in their trade mark spat.
Rival bookmakers Sportsbet and Sportsbetting.com.au have reached a settlement in their trade mark and consumer law dispute, agreeing to drop their claims against each other for unspecified terms.
Two patent attorneys who resigned from Pizzeys Patent and Trade Mark Attorneys to launch a competing business performed work for clients of the boutique IP firm a year after they jumped ship, in breach of their employment contracts, a lawsuit claims.
Two units of US drug giant Johnson & Johnson have filed a lawsuit seeking preliminary discovery from Juno Pharmaceuticals for a possible patent lawsuit over a popular chemotherapy drug used to treat blood cancer.